MicroRNA replacement therapy in cancer - Mollaei - 2019 - Journal of Cellular Physiology - Wiley Online Library
Circulating Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in 11C Choline-identified Oligometastatic Castration-Refractory Prostate Cancer Treated with Stereotactic Ablative Radiotherapy | medRxiv
Tumor markeri – Učimo zajedno
Born to survive: how cancer cells resist CAR T cell therapy | Journal of Hematology & Oncology | Full Text
Tumor marker CEA i CA 19-9, šta su i da li su 100 % sigurni?
Poliklinika Vaše zdravlje - U Poliklinici Vaše zdravlje na najsavremeniji način možete uraditi sve vrste tumor markera. 👩⚕️ Listu tumor markera kao i cjenovnik svih laboratorijskih usluga možete pogledati na https://www.vasezdravlje.ba ...
SERBP1 affects cancer-related phenotypes and tumor growth. a Knockdown... | Download Scientific Diagram
Maligni tumori kostiju - Tumor
Cancers | Free Full-Text | Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment | HTML
Tumor dojke najčešće metastazira u kosti - Tumor
Najčešće korišćeni tumor markeri. - Tumor
Osteosarkom – MladiCe Srbije
Tumor markeri
Imunohemija - CLIA (hemiluminiscenca): Reagensi
Tumor markeri – Učimo zajedno
miR-137: A Novel Therapeutic Target for Human Glioma: Molecular Therapy - Nucleic Acids
Tumori kostiju, maligni, benigni i metastatski tumori kostiju | Kancer
Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation | npj Precision Oncology
Cancers | Free Full-Text | Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield | HTML
PDF) The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation
Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas
A new insight on serum microRNA expression as novel biomarkers in breast cancer patients - Bahmanpour - 2019 - Journal of Cellular Physiology - Wiley Online Library
Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors - ScienceDirect
Targeting PVR (CD155) and its receptors in anti-tumor therapy | Cellular & Molecular Immunology
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice. - Abstract - Europe PMC